CME vs CBOE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CME

37.7
AI Score
VS
CBOE Wins

CBOE

44.7
AI Score

Investment Advisor Scores

CME

38score
Recommendation
SELL

CBOE

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME CBOE Winner
Forward P/E 21.7865 21.978 CME
PEG Ratio 4.68 2.3852 CBOE
Revenue Growth 0.8% 22.9% CBOE
Earnings Growth 2.5% 50.2% CBOE
Tradestie Score 37.7/100 44.7/100 CBOE
Profit Margin 63.4% 26.7% CME
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CBOE

Relative Price Performance (Last 90 Days)

CME 1M: +8.1% · 3M: -4.9% CBOE 1M: +5.6% · 3M: -14.5%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $274.98

CBOE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.5 · Price: $300.74

Fundamentals Snapshot

Metric CME CBOE
Market Cap
Forward P/E 21.3 19.8
Trailing P/E 22.6 22.9
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 1.0% 0.5%
Operating Margin 0.7% 0.3%
EPS 11.97 12.83
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CBOE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.